A. S. Lengyel

Reducing cardiovascular risk in immune‐mediated inflammatory diseases: Tumour necrosis factor inhibitors compared to conventional therapies—A systematic review and meta‐analysis

A. Bánvölgyi, N. Galajda, F. Meznerics, 2024, Journal of the European Academy of Dermatology and Venereology : JEADV.

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts

D. Fenyö, L. Betancourt, C. Welinder, 2024, bioRxiv.

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts

D. Fenyö, L. Betancourt, C. Welinder, 2024, Frontiers in oncology.

MITF regulates IDH1 and NNT and drives a transcriptional program protecting cutaneous melanoma from reactive oxygen species

T. Graeber, Poguan Wang, O. Iliopoulos, 2023, bioRxiv.

MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species

T. Graeber, Poguan Wang, E. Roider, 2024, Scientific reports.